Have a personal or library account? Click to login
Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders Cover

Proton pump inhibitors therapy and risk of hyperprolactinemia with associated sexual disorders

Endocrine Regulations
Volume 56 (2022): Issue 2 (April 2022)
By: Muhammad Ashfaq,  Muhammad Zeeshan Haroon and  Yasser MSA Alkahraman  
Open Access
|Apr 2022

Metrics

DOI: https://doi.org/10.2478/enr-2022-0015 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668
Journal RSS Feed
Language: English
Page range: 134 - 147
Published on: Apr 30, 2022
Published by: Slovak Academy of Sciences, Mathematical Institute
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
proton pump inhibitors,
hyperprolactinemia,
reproductive symptoms,
sexual dys-function,
omeprazole,
gynecomastia,
galactorrhea,
erectile dysfunction
Related subjects:
Life sciences,
Molecular biology,
Neurobiology,
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Internal medicine,
Endocrinology, diabetology

© 2022 Muhammad Ashfaq, Muhammad Zeeshan Haroon, Yasser MSA Alkahraman, published by Slovak Academy of Sciences, Mathematical Institute
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 56 (2022): Issue 2 (April 2022)Next article